Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Menu

    Ondansetron

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,375Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Adial Pharma Announces Journal Publication Supporting AD04 For Alcohol Disorder
    Adial Pharma Announces Journal Publication Supporting AD04 For Alcohol Disorder

    20 Jun 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/06/20/2901669/26135/en/Adial-Pharmaceuticals-Announces-Publication-in-Leading-Peer-Reviewed-Journal-Supporting-the-Potential-Efficacy-of-AD04-as-a-Precision-Medicine-for-the-Treatment-of-Alcohol-Use-Diso.html

    GLOBENEWSWIRE
    20 Jun 2024
    Share Share
    Health Canada Issues Recalls of Accel Pharma's Ondansetron
    Health Canada Issues Recalls of Accel Pharma's Ondansetron

    06 Jun 2024

    // HEALTH CANADA

    https://recalls-rappels.canada.ca/en/alert-recall/accel-ondansetron-odt-4-8-mg-data-integrity-concerns-product-s-bioequivalence-data

    HEALTH CANADA
    06 Jun 2024
    Share Share
    Enforcement Report - Week of December 13, 2023
    Enforcement Report - Week of December 13, 2023

    13 Dec 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-13-2023-38736.pdf

    FDA
    13 Dec 2023
    Share Share
    RedHill's RHB-102 (BEKINDA®) & Opaganib Granted New Patents in Oncology Setting
    RedHill's RHB-102 (BEKINDA®) & Opaganib Granted New Patents in Oncology Setting

    01 May 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/redhills-rhb-102-bekinda-and-opaganib-granted-new-patents-in-oncology-setting-301811839.html

    PR NEWSWIRE
    01 May 2023
    Share Share
    Enforcement Report - Week of February 22, 2023
    Enforcement Report - Week of February 22, 2023

    22 Feb 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-22-2023-51785.pdf

    FDA
    22 Feb 2023
    Share Share
    Heron scores FDA for Aponvie, alternative to pills for postoperative nausea
    Heron scores FDA for Aponvie, alternative to pills for postoperative nausea

    20 Sep 2022

    // Kevin Dunleavy FIERCEPHARMA

    https://www.fiercepharma.com/pharma/heron-scores-fda-go-ahead-aponvie-iv-alternative-pills-postoperative-nausea

    Kevin Dunleavy FIERCEPHARMA
    20 Sep 2022
    Share Share